Clinical Trials Logo

Filter by:
NCT ID: NCT00528567 Completed - Breast Cancer Clinical Trials

BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer

Start date: December 2007
Phase: Phase 3
Study type: Interventional

The main objective of the trial is to compare Invasive Disease-Free Survival (IDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy with 1 year of bevacizumab. The secondary objectives of this trial are to: - compare Overall Survival (OS), Breast Cancer-Free Interval (BCFI), Disease- Free Survival (DFS) and Distant Disease-Free Survival (DDFS) of patients randomised to treatment with adjuvant chemotherapy alone or to adjuvant chemotherapy in combination with 1 year of bevacizumab - evaluate the safety and tolerability of bevacizumab An exploratory sub-study (not reported here) was to identify biomarkers (from tumour or serum) predictive of toxicity and for the level of benefit from the addition of bevacizumab to standard adjuvant systemic treatment.

NCT ID: NCT00526071 Terminated - Fabry Disease Clinical Trials

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

Start date: September 17, 2007
Phase: Phase 2
Study type: Interventional

Study to evaluate the long-term safety, tolerability, and pharmacodynamics (PD) of migalastat hydrochloride (HCl) (migalastat) in participants with Fabry disease

NCT ID: NCT00525993 Unknown status - Sprains and Strains Clinical Trials

Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols

Start date: December 2008
Phase: Phase 4
Study type: Interventional

The investigators will study 2 doses of etoricoxib to prove that 60 mg once daily will be non-inferior to etoricoxib 90mg daily (for 14 days) in the treatment of acute ankle sprain in sports. The investigators objective is to discuss the point that the investigators will follow the minimal dose that is effective for the treatment of this acute condition in orthopedic.

NCT ID: NCT00525967 Unknown status - Pain Clinical Trials

Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain

Start date: February 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine whether oral methadone plus acetaminophen can substitute morphine in the treatment of cancer pain.

NCT ID: NCT00525824 Completed - Atherosclerosis Clinical Trials

12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTORâ„¢) in Combination With Ezetimibe

GRAVITY
Start date: August 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether treatment of Rosuvastatin (CRESTORâ„¢) or Simvastatin given as monotherapy or given in combination with Ezetimibe, will lower the Low Density Lipoprotein Cholesterol (LDL-C) in patients with Hypercholesterolaemia and Coronary Heart Disease (CHD) or a CHD Risk Equivalent, Atherosclerosis or a 10-year CHD Risk of >20%

NCT ID: NCT00525798 Completed - Osteoporosis Clinical Trials

A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

Start date: March 2007
Phase: Phase 3
Study type: Interventional

The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoporosis

NCT ID: NCT00525512 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Tiotropium In Exercise

Start date: August 2007
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily as compared to placebo, in patients with COPD.

NCT ID: NCT00524368 Completed - Clinical trials for Human Immunodeficiency Virus - Type 1

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

ODIN
Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to test if being treated with darunavir/ritonavir (DRV/rtv) 800/100 mg daily is as effective as being treated with DRV/rtv 600/100 mg twice daily, in early antiretroviral (ARV)-experienced patients when given along with selected optimized background regimen (OBR).

NCT ID: NCT00523458 Terminated - HIV Infections Clinical Trials

A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV

OPTI-NNRTI
Start date: July 2007
Phase: Phase 4
Study type: Interventional

Because drugs used to treat TB can reduce the amount of the anti-HIV drugs that reach the sites where the virus is located, this study is designed to see whether it is necessary to use higher doses of antiviral (anti-HIV) drugs while patients are receiving therapy with rifampin, one of the drugs commonly used to treat TB. Participants will be assigned to one of 4 arms (see below) and will be followed during the time when they are receiving both treatments.

NCT ID: NCT00522873 Completed - Postmenopause Clinical Trials

Endometrial Safety Study

Start date: August 2007
Phase: Phase 3
Study type: Interventional

The study is designed to investigate the safety of the investigational product for the lining of the uterus (endometrium).